CIVASTRING PD-103

Source, Brachytherapy, Radionuclide

CIVATECH ONCOLOGY, INC.

The following data is part of a premarket notification filed by Civatech Oncology, Inc. with the FDA for Civastring Pd-103.

Pre-market Notification Details

Device IDK082159
510k NumberK082159
Device Name:CIVASTRING PD-103
ClassificationSource, Brachytherapy, Radionuclide
Applicant CIVATECH ONCOLOGY, INC. 1317 BUCHANAN DR. Mebane,  NC  27302
ContactLois V Smart
CorrespondentLois V Smart
CIVATECH ONCOLOGY, INC. 1317 BUCHANAN DR. Mebane,  NC  27302
Product CodeKXK  
CFR Regulation Number892.5730 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2008-07-31
Decision Date2008-09-30
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00869497000104 K082159 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.